A computational drug metabolite detection using the stable isotopic mass-shift filtering with high resolution mass spectrometry in pioglitazone and flurbiprofen

• Published in: International journal of molecular sciences Vol. 14; no. 10; pp. 19716 - 19730
• Main Authors: Uchida, Masashi, Kanazawa, Mitsuhiro, Ogiwara, Atsushi, Sezaki, Hiroshi, Ando, Akihiro, Miyamoto, Yohei
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 30.09.2013; Molecular Diversity Preservation International (MDPI)
• Subjects: analytical software; Breath tests; Chromatography; Chromatography, Liquid - methods; Computational Biology - methods; drug metabolites; Electronic mail systems; Female; Flurbiprofen - chemistry; Flurbiprofen - metabolism; Fourier transforms; Humans; Identification; Isotope Labeling - methods; Isotopes; Laboratories; Male; Mass spectrometry; mass spectrometry (MS); Mass Spectrometry - methods; Metabolism; Metabolites; metabolites identification; Microsomes, Liver - metabolism; Scientific imaging; Software; stable isotope; Technical Note; Thiazolidinediones - chemistry; Thiazolidinediones - metabolism; Japan
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms141019716

The identification of metabolites in drug discovery is important. At present, radioisotopes and mass spectrometry are both widely used. However, rapid and comprehensive identification is still laborious and difficult. In this study, we developed new analytical software and employed a stable isotope as a tool to identify drug metabolites using mass spectrometry. A deuterium-labeled compound and non-labeled compound were both metabolized in human liver microsomes and analyzed by liquid chromatography/time-of-flight mass spectrometry (LC-TOF-MS). We computationally aligned two different MS data sets and filtered ions having a specific mass-shift equal to masses of labeled isotopes between those data using our own software. For pioglitazone and flurbiprofen, eight and four metabolites, respectively, were identified with calculations of mass and formulas and chemical structural fragmentation analysis. With high resolution MS, the approach became more accurate. The approach detected two unexpected metabolites in pioglitazone, i.e., the hydroxypropanamide form and the aldehyde hydrolysis form, which other approaches such as metabolite-biotransformation list matching and mass defect filtering could not detect. We demonstrated that the approach using computational alignment and stable isotopic mass-shift filtering has the ability to identify drug metabolites and is useful in drug discovery.